GlassScriptPhysician profile
David G Ferachi
NPI 1851576433
$16,263.70
in general payments reported to CMS, 2019-2025
14 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,273 · 2021: $209 · 2022: $76.50 · 2023: $251 · 2024: $132 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $10K · Food and Beverage: $265 · Debt Forgiveness: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $10,278.94 |
| Food and Beverage | $265.32 |
| Debt Forgiveness | $161.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ulrich Medical USA, INC. | $15,489.57 | 2019-2025 | |
| Zimvie INC. | $161.17 | 2023 | |
| Boston Scientific Corporation | $155.63 | 2021-2025 | General - Pain Management |
| Cerapedics INC. | $85.23 | 2019 | |
| Surgalign Spine Technologies, INC. | $68.96 | 2021 | |
| Providence Medical Technology, INC. | $51.13 | 2021 | |
| Abbott Laboratories | $49.57 | 2021-2022 | |
| Horizon Therapeutics Plc | $46.87 | 2019 | |
| Seaspine Orthopedics Corporation | $39.20 | 2019 | |
| Stryker Corporation | $36.53 | 2023 | Optablate |
| Sanara Medtech INC. | $23.05 | 2025 | Celleraterx |
| Medtronic USA, INC. | $22.64 | 2019 | |
| Integrity Implants INC. | $17.27 | 2021 | |
| Ethicon US, LLC | $16.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ferachi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.